Track the Alpha Cognition Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €212.3m. The latest transaction was reported on 24 August 2026 (Acquisition). Among the most active insiders: Opaleye Management Inc.. Every trade is openly available.
52
Insider Decl.
n/a
Thresholds
€4m
42 ops.
Buy Volume
€214,257
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alpha Cognition Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$18.00.
34Σ signal
Buys €4m€214,257 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,374 of 28,899 companies
32.6
score / 100
Value
16
Quality
49
FCF yld-9.7%
Earn yld-9.7%
EV/EBITDA·
ROE-50%
Gross mgn81%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,481 shares@ US$5.7490.8% of flowCommon Stock, no par valueSEC:0001493152-26-011902:0
Canonical exit: 16 Jun 2026 (T+90)
25 of 52 declarations
About Alpha Cognition Inc.
Alpha Cognition Inc. is a company focused on developing treatments for cognitive disorders, including Alzheimer's disease. It is listed on the XNAS market.